GCG and obesity disorder: Glucagon-like peptide-1 (GLP-1) and dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists are highly effective therapies for overweight and obesity due to their potent ability to provide significant amounts of weight loss.